This health problem cause half of new diabetes cases annually in U.S.
In a new study from Northwestern University, researchers found that reducing the prevalence of obesity may prevent up to half of new Type 2...
Common drugs for type 2 diabetes and obesity do not increase breast cancer risk
In a new study from the Universidade Federal do Rio Grande do Sul, researchers found that commonly used medications for type 2 diabetes and...
Scientists find new way to reduce diabetes-related eye disease
In a new study from Indiana University, researchers found that early treatment with anti-VEGF injections reduces diabetic retinopathy.
Their 2-year results suggest that close monitoring...
Fasting acts as diet catalyst in people with metabolic syndrome
One in four Germans suffers from metabolic syndrome.
Several of four diseases of affluence occur at the same time in this 'deadly quartet': obesity, high...
Common diabetes drug could strongly cut COVID-19 death risk
In a recent study at the University of Alabama at Birmingham, researchers found that the use of the diabetes drug metformin—before a diagnosis of...
Weekly insulin can help manage type 2 diabetes effectively
In a new study, researchers found that a new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low...
Newer diabetes drug can protect kidney and heart health
In a recent study at Brigham and Women’s Hospital, researchers found new evidence that sodium/glucose cotransporter 2 (SGLT2) inhibitors can benefit patients with diabetes...
Scientists find the key to new therapies for Alzheimer’s disease, diabetes
In a new study, researchers examined the role of cholesterol in both Alzheimer's disease and Type 2 diabetes.
They found a small molecule that may...
Scientists find a powerful new way to treat diabetic foot ulcers
In a new study, researchers found a powerful new approach for treating diabetic foot ulcers, which affect millions of people in the US and...
This diabetes drug could reduce body fat in people with obesity
In a new study, researchers found that in adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide...